BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23306326)

  • 1. Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: a nationwide propensity score-matched follow-up study.
    Mortensen JK; Larsson H; Johnsen SP; Andersen G
    Stroke; 2013 Feb; 44(2):420-6. PubMed ID: 23306326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of prestroke selective serotonin reuptake inhibitor treatment on stroke severity and mortality.
    Mortensen JK; Larsson H; Johnsen SP; Andersen G
    Stroke; 2014 Jul; 45(7):2121-3. PubMed ID: 24893612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrovascular, Cardiovascular, and Mortality Events in New Users of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: A Propensity Score-Matched Population-Based Study.
    Leong C; Alessi-Severini S; Enns MW; Nie Y; Sareen J; Bolton J; Prior HJ; Chateau D
    J Clin Psychopharmacol; 2017 Jun; 37(3):332-340. PubMed ID: 28383363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of serotonin-norepinephrine reuptake inhibitors versus selective serotonin reuptake inhibitors on cerebrovascular events.
    Lee YC; Lin CH; Lin MS; Lu Y; Chang CH; Lin JW
    J Clin Psychiatry; 2016 Jan; 77(1):e1-7. PubMed ID: 26845272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute ischemic stroke and long-term outcome after thrombolysis: nationwide propensity score-matched follow-up study.
    Schmitz ML; Simonsen CZ; Hundborg H; Christensen H; Ellemann K; Geisler K; Iversen H; Madsen C; Rasmussen MJ; Vestergaard K; Andersen G; Johnsen SP
    Stroke; 2014 Oct; 45(10):3070-2. PubMed ID: 25190440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Serotonin Reuptake Inhibitors and Poststroke Epilepsy: A Population-Based Nationwide Study.
    Chou CC; Yen DJ; Lin YY; Wang YC; Lin CL; Kao CH
    Mayo Clin Proc; 2017 Feb; 92(2):193-199. PubMed ID: 28160872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Pretreatment versus De Novo Treatment with Selective Serotonin Reuptake Inhibitors on Short-term Outcome after Acute Ischemic Stroke.
    Siepmann T; Kepplinger J; Zerna C; Schatz U; Penzlin AI; Pallesen LP; Illigens BM; Weidner K; Reichmann H; Puetz V; Bodechtel U; Barlinn K
    J Stroke Cerebrovasc Dis; 2015 Aug; 24(8):1886-92. PubMed ID: 26099557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis in acute ischemic stroke is associated with lower long-term hospital bed day use: A nationwide propensity score-matched follow-up study.
    Terkelsen T; Schmitz ML; Simonsen CZ; Hundborg HH; Christensen HK; Gyllenborg J; Sandal BF; Iversen HK; Madsen C; Rasmussen MJ; Vestergaard K; Andersen G; Johnsen SP
    Int J Stroke; 2016 Oct; 11(8):910-916. PubMed ID: 27312677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of hospitalization for upper gastrointestinal bleeding in users of selective serotonin reuptake inhibitors after Helicobacter pylori eradication therapy: a propensity score matching analysis.
    Guo CG; Cheung KS; Zhang F; Chan EW; Chen L; Wong ICK; Leung WK
    Aliment Pharmacol Ther; 2019 Nov; 50(9):1001-1008. PubMed ID: 31583734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study.
    Bak S; Tsiropoulos I; Kjaersgaard JO; Andersen M; Mellerup E; Hallas J; García Rodríguez LA; Christensen K; Gaist D
    Stroke; 2002 Jun; 33(6):1465-73. PubMed ID: 12052976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.
    Sehested TSG; Gerds TA; Fosbøl EL; Hansen PW; Charlot MG; Carlson N; Hlatky MA; Torp-Pedersen C; Gislason GH
    J Intern Med; 2018 Mar; 283(3):268-281. PubMed ID: 29024109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebral Hemorrhage and Outcome After Thrombolysis in Stroke Patients Using Selective Serotonin-Reuptake Inhibitors.
    Scheitz JF; Turc G; Kujala L; Polymeris AA; Heldner MR; Zonneveld TP; Erdur H; Curtze S; Traenka C; Brenière C; Wiest R; Rocco A; Sibolt G; Gensicke H; Endres M; Martinez-Majander N; Béjot Y; Nederkoorn PJ; Oppenheim C; Arnold M; Engelter ST; Strbian D; Nolte CH;
    Stroke; 2017 Dec; 48(12):3239-3244. PubMed ID: 29127269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preadmission use of selective serotonin reuptake inhibitors and short-term mortality in diabetic patients hospitalized due to stroke.
    Würtz M; Schmidt M; Grove EL; Horváth-Puhó E; Christiansen CF; Sørensen HT
    J Intern Med; 2016 Oct; 280(4):407-18. PubMed ID: 27138221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study.
    Douros A; Dell'Aniello S; Dehghan G; Boivin JF; Renoux C
    Neurology; 2019 Sep; 93(10):e1010-e1020. PubMed ID: 31391245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of secondary medical prophylaxis and clinical outcome among patients with ischemic stroke: a nationwide follow-up study.
    Palnum KH; Mehnert F; Andersen G; Ingeman A; Krog BR; Bartels PD; Johnsen SP
    Stroke; 2012 Mar; 43(3):802-7. PubMed ID: 22207506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updating the Evidence of the Interaction Between Clopidogrel and CYP2C19-Inhibiting Selective Serotonin Reuptake Inhibitors: A Cohort Study and Meta-Analysis.
    Bykov K; Schneeweiss S; Glynn RJ; Mittleman MA; Bates DW; Gagne JJ
    Drug Saf; 2017 Oct; 40(10):923-932. PubMed ID: 28623527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Selective Serotonin Reuptake Inhibitors on Cardiovascular Outcomes After Percutaneous Coronary Intervention: A Retrospective Cohort Study.
    Iasella CJ; Kreider MS; Huang L; Coons JC; Stevenson JM
    Clin Drug Investig; 2019 Jun; 39(6):543-551. PubMed ID: 30900189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups.
    Juul N; Gislason G; Olesen JB; Lamberts M; Hansen ML; Karasoy D; Christiansen CB; Torp-Pedersen C; Sorensen R
    Eur Heart J Acute Cardiovasc Care; 2017 Sep; 6(6):511-521. PubMed ID: 24936092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
    Labos C; Dasgupta K; Nedjar H; Turecki G; Rahme E
    CMAJ; 2011 Nov; 183(16):1835-43. PubMed ID: 21948719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study.
    Horsdal HT; Mehnert F; Rungby J; Johnsen SP
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):717-25. PubMed ID: 21536457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.